Health
NIH to conduct large trial for COVID-19 polyclonal antibody therapies – News-Medical.Net
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted…
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
Non-hospitalized people with mild or moderate cases of COVID-19 are to be enrolled at sites around the world, for a test trial called ACTIV-2, which is a part of NIH’s Accelerating COVID-19 Therapeutic Interventions…
-
Noosa News12 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General21 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Business8 hours agoWhere next for the CBA share price?
-
General22 hours agoRed tape on chopping block in bid to build homes faster